Unlearn, an AI-enabled company creating digital twins of clinical trial participants, announced it scored $50 million in Series C funding, bringing its total raise to more than $130 million. Altimeter Capital led the round with…
Continue Reading
What You Should Know:
– Unlearn®, a leading AI company using digital twins to revolutionize clinical trials, announced today a $50M Series C funding round led by Altimeter Capital. This investment, bringing Unlearn’s total funding…
Continue Reading
Elephas, an oncology-focused diagnostics platform, announced it secured $55 million in Series C funding, bringing its total raise to $116.5 million. Venture Investors Health Fund and the State of Wisconsin Investment Board (SWIB) led the…
Continue Reading
Digital metabolic care startup Twin Health announced it raised $50 million in funding, two years after securing $140 million in Series C funding. Temasek led the funding with participation from existing investors Sofina, ICONIQ Growth,…
Continue Reading
Technology-enabled healthcare provider Doctor Anywhere from Singapore has raised another $40.8 million in a Series C funding extension round joined by Square Peg and Novo Holdings. This brings its total investments since inception to nearly…
Continue Reading
Recent Series C Financing of Leading Non-Emergency Medical Transportation Platform Fuels Rapid National Expansion
SEMCAP Health announces its continued support of portfolio company, SafeRide Health, with participation in the company’s recently announced Series C funding. This…
Company Expands Industry’s Most Sophisticated AI-Enabled Radiology Performance Platform with Acquisition of CoRead
Covera Health, the leading AI-enabled diagnostic technology company focused on radiology performance measurement and impact, today announced up to $50 million in additional Series C…
Cytovale, a medical diagnostics company focused on developing technology that helps diagnose diseases, announced it scored $84 million in Series C funding led by Norwest Venture Partners with participation from other investors. WHAT THEY DO
Cytovale…
Neurophet scores $15M in Series C funding, announces 2024 IPOSouth Korean company Neurophet, a provider of brain image analysis software, has raised 20 billion won ($15 million) in a Series C funding round participated by…
Continue Reading
Sepsis kills more than 11 million people worldwide each year and contributes to 20% of all global deaths. The disease is also a leading cause of death in U.S. hospitals, and a septic patient’s…
Continue Reading
